MacuLogix Featured on Talk Radio Show
MacuLogix Clinical Team to be Featured on Optometry’s Talk Radio Show
“Practical Guidelines for the Treatment of AMD” will be the focus of an upcoming episode of The Power Hour
MIDDLETOWN, PA, February 9, 2018 – MacuLogix®, Inc., the only company to equip eye care professionals with the instrument, tools, and education needed to effectively diagnose and treat patients with age-related macular degeneration (AMD), announces that MacuLogix Co-Founder and Chief Technology Officer Greg Jackson, PhD, and Clinical Advisor Jeffry Gerson, OD, FAAO, will be the featured guests on the Power Hour, optometry’s only live talk radio show!
The Power Hour is led by a well-known optometrist and practice management consultant, Gary Gerber, OD. Dr. Gerber is also an accomplished musician and the founder and owner of The Power Practice, a New Jersey-based optometry consulting company.
This special episode of the Power Hour airs on Wednesday, February 21, 2018 at 9:00pm EST. Drs. Jackson and Gerson will be discussing the recently released “Practical Guidelines for the Treatment of AMD,” which were published in the October issue of Review of Optometry. The show will explore how these practical, evidence-based guidelines are easy to follow and can be implemented in any practice to help eliminate AMD vision loss while contributing to practice profitability.
To tune in, call 646-716-8746 or call in from your computer at http://www.powerhour.info. Dr. Gerber will take live call-in questions during the show.
MacuLogix, Inc. equips eye care professionals with the instrument, tools, and education needed to effectively diagnose and treat patients with AMD. By leveraging the science of dark adaptation through its AdaptDx®, MacuLogix is working to eliminate preventable blindness caused by AMD, a chronic, progressive disease that impacts over 170 million people worldwide and goes undiagnosed in 25 percent of patients. Through its AdaptDx dark adaptation biomarker, MacuLogix enables eye care professionals to detect, monitor, and treat AMD three years before it can be seen clinically. MacuLogix provides in-practice training and treatment best practices to support the implementation and optimization of the AdaptDx.